PAX7 and facioscapulohumeral muscular dystrophy: To confirm that our PAX7 biomarker does not discriminate FSHD status from control by chance, we performed a resampling procedure, selecting 1000 random gene sets of equivalent size to both the upregulated and downregulated PAX7 target gene sets.